Form 4 for ALKS Alkermes plc.
Accepted 2025-11-03 00:00:00 ET · period of report 2025-11-03 · accession 0001520262-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-03 | 2025-11-03 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $30.38 | -9,000 | 69.7K | -11% | -$273.4K |
| D | 2025-11-03 | 2025-11-03 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $19.34 | +5,000 | 78.7K | +7% | +$96.7K |
| D | 2025-11-03 | 2025-11-03 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $0.00 | -5,000 | 40.1K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-03 | S | D | 9,000 | $30.38 | 69,740 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.34 to $30.56. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |
| 2 | Common | Ordinary Shares | 2025-11-03 | M | A | 5,000 | $19.34 | 78,740 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2025-11-03 | M | D | 5,000 | $0.00 | 40,104 | D | $19.34 · — to 2031-02-22 | 5,000 Ordinary Shares | (F4) These options are fully vested in accordance with their terms. |